Shohei Ohtani’s stay on the injured list may be headed toward a longer wait than the Dodgers first made it sound.
Ohtani had appeared in just one game over an eight-day stretch before Los Angeles finally put him on the 15-day IL on Friday, and the delay raised an obvious question: why not make the move sooner? The answer, at least for a while, was tied to hope that he could still serve as a designated hitter or even come off the bench to pinch-hit and keep his roster spot.
That possibility no longer seems nearly as close.
Ohtani did not travel with the Dodgers to Miami for their three-game set against the Marlins, and manager Dave Roberts said Saturday that the two-way star has not restarted baseball activities. The earliest Los Angeles can bring him back is Sept. 23, which would leave him only five regular-season games to get ready before the postseason.
Roberts said in Miami that Ohtani will spend “a few days” away from swinging a bat before being re-evaluated to see when he can pick things back up.
The manager, speaking from 3,000 miles away from the player, said there still wasn’t a more specific diagnosis to point to.
“There’s nothing as far as the diagnosis, as far as anything that’s outside of just it’s bothersome. His right bicep is bothersome when he swings,” the manager said.
“The knee is still sore, but right now it’s the bicep, arm, that’s kind of bothering. But I don’t know outside of what more specific I can say than the bicep.”
Roberts also said earlier this week that he regretted how the Dodgers handled the situation.
“I think if we look right now, here today, I would love to go back and put him on the IL [last week],” Roberts said on Wednesday. “But I did feel at that moment in time, we all felt that giving him four days was sufficient. He was agreeable."
With Ohtani out, the Dodgers recalled Josue De Paula from Double-A to fill the roster spot. The 21-year-old has opened his first two games without a hit, but he has drawn four walks and scored once in his first nine plate appearances.
In Other News...
Dodgers Just Raised The Stakes For Two Fast-Rising Outfield Prospects
The Dodgers are using the stretch run to get a longer look at some of their fastest-rising young outfielders. Josue De Paula was brought up to fill in for injured Shohei Ohtani, and now Charles Davalan and Eduardo Quintero have also moved up, leaving advanced Class-A Great Lakes for Double-A Tulsa. It is the kind of late-season shuffle that gives the organization a better read on where its top prospects stand without waiting for next spring.
For a club that always seems to be balancing October aspirations with player development, the timing matters. Tulsa is a tougher test, and it gives both Davalan and Quintero a chance to face a higher level of pitching before the playoffs arrive, while the Dodgers continue sorting out which young bats are closest to helping at the next level. [Read more 🡒]
Dodgers Suddenly Face A Massive Tarik Skubal Problem
Tarik Skubal has quickly become one of the most intriguing names on the Dodgers radar, and not just because of what he has done on the mound since arriving. The left-hander has held up well in seven starts, posting a 2.93 ERA and giving Los Angeles the kind of frontline production teams spend all winter chasing.
The complication is what comes next. Skubal is expected to hit free agency this winter, and he projects to be one of the highest-paid pitchers in baseball history, with contract estimates landing somewhere in the $400 million to $500 million range. The Dodgers and Blue Jays are viewed as early favorites, which only raises the stakes for a club that now has to weigh how far it is willing to go to keep a pitcher who has already looked like a fit. [Read more 🡒]
Miguel Rojas Injury Scare Leaves Dodgers Facing An Infield Question
Miguel Rojas has been managing the kind of shoulder issue that can quietly shape a season long before it ever shows up on the injury report. During the Dodgers game against the Marlins, he had to leave after aggravating a labrum tear, a reminder that one of the clubs steadiest infield pieces has been playing through discomfort for most of his career while trying to stay available.
Rojas plans to get a cortisone injection in hopes of keeping him on the field, but the Dodgers may still have to think ahead if the soreness lingers. They do have depth options to cover his spot, which softens the immediate blow, though any extended absence would still leave an infield question for a team trying to manage the stretch run as cleanly as possible. [Read more 🡒]